STOCK TITAN

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Certara (CERT), a leader in model-informed drug development, has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to present on Wednesday, January 15th, 2025, at 5:15 PM Pacific Time.

Investors and interested parties can access a live webcast of the presentation through Certara's investor relations website at https://ir.certara.com. The presentation recording will remain available for replay on the website for a minimum of 30 days following the event.

Certara (CERT), leader nello sviluppo di farmaci basato su modelli, ha annunciato la sua partecipazione alla prossima 43ª Conferenza Annuale J.P. Morgan Healthcare. Il team di gestione dell'azienda presenterà il mercoledì 15 gennaio 2025, alle 17:15 ora del Pacifico.

Investitori e parti interessate possono accedere a un webcast dal vivo della presentazione tramite il sito web delle relazioni con gli investitori di Certara all'indirizzo https://ir.certara.com. La registrazione della presentazione rimarrà disponibile per la visione on-demand sul sito per un minimo di 30 giorni dopo l'evento.

Certara (CERT), líder en el desarrollo de fármacos informado por modelos, ha anunciado su participación en la próxima 43ª Conferencia Anual de J.P. Morgan Healthcare. El equipo de gestión de la compañía está programado para presentar el miércoles 15 de enero de 2025, a las 5:15 PM hora del Pacífico.

Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través del sitio web de relaciones con inversores de Certara en https://ir.certara.com. La grabación de la presentación estará disponible para su reproducción en el sitio durante un mínimo de 30 días después del evento.

Certara (CERT)는 모델 정보를 바탕으로 한 약물 개발의 선두주자로, 다가오는 제43회 J.P. Morgan 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 회사 경영진은 2025년 1월 15일 수요일 오후 5시 15분(태평양 시간)에 발표할 예정입니다.

투자자와 관심 있는 분들은 Certara의 투자자 관계 웹사이트 https://ir.certara.com를 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다. 발표 녹화는 이벤트 이후 최소 30일 동안 사이트에서 재생 가능할 것입니다.

Certara (CERT), un leader dans le développement de médicaments informé par des modèles, a annoncé sa participation à la prochaine 43e Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de l'entreprise est programmée pour présenter le mercredi 15 janvier 2025, à 17h15, heure du Pacifique.

Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct de la présentation via le site web des relations investisseurs de Certara à l'adresse https://ir.certara.com. L'enregistrement de la présentation restera disponible en replay sur le site pendant un minimum de 30 jours après l'événement.

Certara (CERT), ein führendes Unternehmen in der modellinformierten Arzneimittelentwicklung, hat seine Teilnahme an der bevorstehenden 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Das Management-Team des Unternehmens wird am Mittwoch, den 15. Januar 2025, um 17:15 Uhr pazifischer Zeit präsentieren.

Investoren und Interessierte können über die Website der Investor Relations von Certara unter https://ir.certara.com auf ein Live-Webcast der Präsentation zugreifen. Die Aufzeichnung der Präsentation wird mindestens 30 Tage nach der Veranstaltung auf der Website zur Verfügung stehen.

Positive
  • None.
Negative
  • None.

RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference.

Company management will present at 5:15PM PT on Wednesday, January 15th, 2025.

A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 30 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Alyssa Horowitz
certara@pancomm.com


FAQ

When is Certara (CERT) presenting at the 2025 J.P. Morgan Healthcare Conference?

Certara (CERT) is scheduled to present at 5:15 PM Pacific Time on Wednesday, January 15th, 2025.

How can investors watch Certara's presentation at the J.P. Morgan Healthcare Conference?

Investors can watch the live webcast of Certara's presentation through the company's investor relations website at https://ir.certara.com.

How long will Certara's J.P. Morgan Healthcare Conference presentation be available for replay?

The presentation will be available for replay on Certara's investor relations website for at least 30 days after the event.

Which healthcare conference is Certara (CERT) participating in January 2025?

Certara is participating in the 43rd Annual J.P. Morgan Healthcare Conference in January 2025.

Certara, Inc.

NASDAQ:CERT

CERT Rankings

CERT Latest News

CERT Stock Data

1.87B
120.84M
2.27%
96.13%
2.65%
Health Information Services
Services-prepackaged Software
Link
United States of America
RADNOR